Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Prader Willi SyndromeAdrenal Insufficiency
Interventions
OTHER

Low dose (1 mcg) ACTH stimulation test

Subjects will have baseline cortisol and ACTH drawn followed by administration of 1 mcg/m2 (max 1 mcg) of cortrosyn. Blood will be drawn at 20 and 40 minutes post cortrosyn for peak cortisol assessment of central adrenal insufficiency.

OTHER

Overnight metyrapone test

Subjects will receive metyrapone 30 mg/kg (max 3 grams) by mouth at midnight. Blood will be drawn at 0800 AM the following morning for ACTH, cortisol and 11 deoxycortisol for assessment of central adrenal insufficiency.

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Nationwide Children's Hospital

OTHER

NCT02368379 - Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome | Biotech Hunter | Biotech Hunter